Berlin - Delayed Quote EUR
BeiGene Ltd (49BA.BE)
222.00
-10.00
(-4.31%)
At close: May 2 at 8:04:44 AM GMT+2
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 49BA.BE | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | RBC Capital: Outperform to Outperform | 4/28/2025 |
| Reiterates | TD Securities: Buy to Buy | 4/24/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 4/21/2025 |
| Reiterates | Guggenheim: Buy to Buy | 4/16/2025 |
| Reiterates | Guggenheim: Buy to Buy | 4/10/2025 |
| Initiated | RBC Capital: Outperform | 4/7/2025 |
Related Tickers
UR8.BE UroGen Pharma Ltd. R
10.20
0.00%
GON.F Geron Corporation
1.2200
+1.67%
I9SA.F Verona Pharma plc
62.20
-1.58%
ZH6.BE Biohaven Ltd. R
20.20
+2.54%
ACUT AccuStem Sciences, Inc.
0.4997
-9.10%
DYAI Dyadic International, Inc.
1.1992
-0.07%
ENTO Entero Therapeutics, Inc.
0.3640
+2.82%
SABS SAB Biotherapeutics, Inc.
1.6000
-6.98%
AIMI AIM ImmunoTech Inc.
0.0900
+6.01%
VCNX Vaccinex, Inc.
0.6700
-33.00%